M
Marion Ferner
Researcher at University of Mainz
Publications - 19
Citations - 817
Marion Ferner is an academic researcher from University of Mainz. The author has contributed to research in topics: Cardiac surgery & Clinical endpoint. The author has an hindex of 9, co-authored 18 publications receiving 674 citations.
Papers
More filters
Journal ArticleDOI
A Multicenter Trial of Remote Ischemic Preconditioning for Heart Surgery
Patrick Meybohm,Berthold Bein,Oana Brosteanu,Jochen Cremer,Matthias Gruenewald,Christian Stoppe,Mark Coburn,G. Schaelte,Andreas Böning,Bernd Niemann,Jan P. Roesner,Frank Kletzin,U. Strouhal,Christian Reyher,Rita Laufenberg-Feldmann,Marion Ferner,I. F. Brandes,Martin Bauer,Sebastian Stehr,Andreas Kortgen,Maria Wittmann,Georg Baumgarten,Tanja Meyer-Treschan,Peter Kienbaum,Matthias Heringlake,Julika Schön,Michael Sander,Sascha Treskatsch,Thorsten Smul,Ewa Wolwender,Thomas F. Schilling,Georg Fuernau,Dirk Hasenclever,Kai Zacharowski +33 more
TL;DR: Upper-limb RIPC performed while patients were under propofol-induced anesthesia did not show a relevant benefit among patients undergoing elective cardiac surgery.
Journal ArticleDOI
Hydroxychloroquine in children with interstitial (diffuse parenchymal) lung diseases
TL;DR: A literature research on the usage of chloroquine (CQ) and HCQ in these conditions was done.
Journal ArticleDOI
Rationale and design of the RE-LATED AF—AFNET 7 trial: REsolution of Left atrial-Appendage Thrombus—Effects of Dabigatran in patients with Atrial Fibrillation
Marion Ferner,Daniel Wachtlin,Torsten Konrad,Oliver Deuster,Thomas Meinertz,Stephan von Bardeleben,Thomas Münzel,Monika Seibert-Grafe,Günter Breithardt,Thomas Rostock +9 more
TL;DR: This is the first prospective, multicentre, randomized controlled clinical trial investigating safety and efficacy of a NOAC for the resolution of LAA thrombi in patients with non-valvular AF.
Journal ArticleDOI
Kinetics of plasma biomarkers of inflammation and lung injury in surgical patients with or without postoperative pulmonary complications
Serpa Neto A,Campos Pp,Sabrine N.T. Hemmes,Lieuwe D. J. Bos,Thomas Bluth,Marion Ferner,Andreas Güldner,M. W. Hollmann,India I,Thomas Kiss,Rita Laufenberg-Feldmann,Juraj Sprung,Demet Sulemanji,Carmen Unzueta,Melo Mf,Toby N. Weingarten,Boer Am,Paolo Pelosi,Gama de Abreu M,Marcus J. Schultz +19 more
TL;DR: In patients undergoing abdominal surgery and at risk of developing PPCs, plasma levels of biomarkers for inflammation or lung injury showed distinct kinetics with development of P PCs, but none of the biomarkers showed sufficient prognostic value.
Journal ArticleDOI
Prevalence of pain 6 months after surgery: A prospective observational study
TL;DR: It is revealed that a significant percentage of patients undergoing procedures in joint or back surgery still need pain medication up to 6 months postoperatively due to ongoing pain symptoms.